NewsSource: EClinCloud official website historical archive

EClinCloud Partners with Yuanzi Technology's eHuiQian to Further Advance Clinical Research Compliance

3 min readEClinCloud Editorial Team
Archived article cover: EClinCloud partners with Yuanzi Technology eHuiQian to further advance clinical research compliance

In October 2025, EClinCloud partnered with Yuanzi Technology on the compliant electronic signature system eHuiQian. Together, both parties will leverage an intelligent, interconnected technology framework to provide digital compliance support for global clinical research projects.

一临云与源资科技标识  

 

Compliance Assurance: Building a Global Trust Framework

 

Developed by Yuanzi Technology, eHuiQian has global compliance capabilities and meets the compliance requirements of major international regulations and standards, including the Electronic Signature Law of the People's Republic of China, FDA 21 CFR Part 11, and EU Annex 11. It supports multiple compliance mechanisms—including enterprise CA certificates, timestamping, tamper protection, and audit trails—providing a reliable electronic evidence chain for cross-border pharmaceutical regulatory audits.

Leveraging its multilingual, multi-time-zone, and multicenter international project support capabilities, EClinCloud has accumulated extensive practical experience in global regulatory compliance and data standardization; the EClinCloud intelligent cloud platform, through this integration with eHuiqian (e慧签), can more conveniently achieve data integrity, traceability, and reliability.

 

 

Intelligent Collaboration, Enabling Efficient Operations

 

This collaboration will establish end-to-end workflow connectivity for clinical research documents within the system. Documents ranging from study protocols and data management reports to quality agreements and other records can all be signed online within the EClinCloud platform, with a full audit trail recorded throughout.

At the same time, by leveraging interoperability among EClinCloud's eTMF, CTMS, and EDC systems, an automated closed loop from signing to archiving will be progressively achieved; clinical research document approval cycles will be shortened by more than 80%, significantly improving project advancement and quality management efficiency.

Building on this collaboration, both parties will continue to deepen collaborative innovation in system interoperability, compliance standards, and intelligent workflows, working together to build a digital compliance ecosystem covering the full clinical R&D lifecycle.

 

 

About EClinCloud

EClinCloud is a leading AI technology company in the clinical research industry. Driven by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and accurate digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug/device R&D cycles to benefit patients.

 

 

About Tri-I Biotech

Yuanzi Information Technology (Shanghai) Co., Ltd. was founded in 2008. Its business spans bioinformatics, drug R&D, materials R&D, clinical trial design and data analysis, and enterprise quality information management, and it is a high-tech enterprise providing comprehensive software solutions and consulting services. Leveraging professional software and strong service capabilities, the company provides compliant, innovative IT solutions for enterprises, hospitals, universities, research institutions, and other organizations. To date, it has done business with more than 300 well-known domestic pharmaceutical, chemical, and high-tech enterprises, established collaborations with over 2000 universities and research institutes, and served more than 100 research institutes and hospitals through its clinical projects, earning the trust of many clients.